Overview
Sevoflurane and Propofol for Botulinum Toxin Injection
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2026-02-28
2026-02-28
Target enrollment:
0
0
Participant gender:
All
All
Summary
The investigators would like to compare clinical features (onset, duration, emergence time), efficacy of deep sedation (successful completion of procedure), safety (adverse events) and caregiver's satisfaction for sedation when used propofol and sevoluflurane for deep sedation in 3-11 year old pediatric patients with spastic cerebral palsy receiving botulinum toxin injection.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Yeungnam University College of MedicineTreatments:
Propofol
Sevoflurane
Criteria
Inclusion Criteria:- Children with cerebral palsy (ages 3-11)
Exclusion Criteria:
① Obestity : Body Mass Index of 30 kg/m2 or more
- Heart disease : NYHA class >2
- Laryngomalacia
- Acute upper respiratory disease or asthma ⑤ Gastroesophageal reflux disease
⑥ Allergy to general anesthetics and drugs planned for use in this study